JSR and IBM Quantum Envision a Revolution in Semiconductor Manufacturing
16 February 2023
IBM and JSR chart a new future for the global semiconductor industry, with quantum computing solutions to hard chemical engineering problems.
Watch the video below and visit the case study released by IBM at the following link:
Case Study：https://ibm.com/case-studies/jsr
Share with friends:
17 September 2024
JSR Life Sciences to Launch Amsphere™ A+, a Next-Generation Protein A Resin for Antibody Drug Purification
JSR Life Sciences, a JSR Group company, today announced the launch of its next generation protein A chromatography resin, Amsphere™ A+.
16 May 2024
JSR to make Yamanaka Hutech, a manufacturer of high-purity chemicals for semiconductors, a wholly owned subsidiary
30 November 2023
New Energy Collaborative Aims to Accelerate Creation of Low-Carbon Energy Access in Asia-Pacific for the Semiconductor Climate Consortium
2 November 2022
JSR Joins Semiconductor Climate Consortium as Founding Member
JSR Corporation today announced it has become a founding member of the new Semiconductor Climate Consortium (SCC), a group formed with other companies from across the semiconductor value chain and SEMI, the global industry association representing the electronics manufacturing and design supply chain.
13 October 2022
JSR Electronic Materials Korea to be a JSR Wholly Owned Subsidiary
SR Corporation (Representative Director, CEO: Eric Johnson, “JSR”) announced today that it has signed a Share Purchase Agreement to acquire the 60% of shares held by PERI Corporation (“PERI”) and make JSR Electronic Materials Korea Co., Ltd. ("JEMK") a wholly owned subsidiary of JSR. JEMK is a joint venture between PERI and JSR, which is the sales agent/distributor of its Electronic Materials business in Korea.
15 March 2022
JSR Life Sciences’ Amsphere A3 Integrated into the Commercial Manufacturing of FDA-Approved Antibody Therapy
11 October 2021
